developed capripoxvirus recombinant vaccines (rCPV) expressing either H or F gene of rinderpest virus.
developed a recombinant capripoxvirus (rCPV) vaccine by inserting F gene of PPRV into the genome of the attenuated capripoxvirus strain KS-1.
A recombinant capripoxvirus vaccine construct expressing a major core structural protein VP7 of Bluetongue virus serotype 1 (BTV-1) was developed.
developed recombinant vaccine construct by inserting the Gn and Gc glycoprotein genes of RVFV into the TK gene locus of KS1 strain of capripoxvirus.
The development of recombinant capripoxvirus vectored vaccines described in the present review rely mainly on the cloning and recombination strategies adopted for developing vaccinia virus-based recombinant vaccines.
However, for livestock farmers in developing countries like India, the cost is the major factor impeding the success of recombinant capripoxvirus based vaccines to combat numerous diseases affecting livestock.
Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease.
Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections.
Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses.
Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vector.
A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV).